Insiders Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
24.78 ^USD	+0.08%		-6.10%	-16.06%

05-10	Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating	MT
05-08	Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mirum Pharmaceuticals, Inc. Announces Management Changes	01-16	CI
Mirum Pharmaceuticals Names Joanne Quan as Chief Medical Officer	01-16	MT
Mirum Pharmaceuticals, Inc. Announces Management Appointments	01-16	CI
Mirum Pharmaceuticals Insider Bought Shares Worth $256,791, According to a Recent SEC Filing	13/09/23	MT
Mirum Pharmaceuticals, Inc. Appoints Eric Bjerkholt as the Chief Financial Officer	11/09/23	CI
Mirum Pharmaceuticals Appoints Eric Bjerkholt as Finance Chief	11/09/23	MT
Insider Buy: Mirum Pharmaceuticals	05/09/23	MT
Insider Sell: Mirum Pharmaceuticals	05/05/23	MT
Mirum Pharmaceuticals, Inc. Announces Board Changes	06/04/23	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Ian Clements as Chief Financial Officer	09/01/23	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Carol L. Brosgart, M.D. as A Director of the Company and as A Member of the Nominating and Corporate Governance Committee of the Board, Effective December 19, 2022	19/12/22	CI
Mirum Pharmaceuticals, Inc. Appoints Lon Cardon to Board of Directors	19/12/22	CI
Insider Sell: Mirum Pharmaceuticals	16/11/22	MT
Mirum Pharmaceuticals, Inc. Announces Resignation of Edward T. Mathers as A Member of the Compensation Committee of the Board, Effective September 1, 2022	02/09/22	CI
Mirum Pharmaceuticals, Inc. Appoints Saira Ramasastry to the Board of Directors and as A Member of the Audit Committee	06/06/22	CI
Insider Buy: Mirum Pharmaceuticals	30/11/21	MT
Mirum Pharmaceuticals, Inc. Announces Board Changes	19/08/21	CI
Mirum Pharmaceuticals, Inc. Appoints Carol L. Brosgart, M.D. to Board of Directors	07/06/21	CI
Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer	28/04/20	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Michael Grey as Executive Officer, Effective from January 1, 2020	27/12/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Insiders

Filters